Epidemiologic Study Of The Distribution Of Vaccine-Type Streptococcus Pneumoniae Serotypes In Adults In The US With Community-Acquired Pneumonia

Pfizer

Status: Completed

Conditions: Vaccines, Pneumococcal; Pneumonia, Pneumococcal

Treatments: Procedure: Urine sample collection

Study type: Observational

Funder types: Industry

Identifiers

NCT01086397

6115A1-4007

B1851032

Details and patient eligibility

About

The main purpose of this study is to use an investigational urine assay to estimate the proportion of pneumonia in adults 50 years or older in different areas throughout the US that is caused by certain types of the bacteria Streptococcus pneumoniae (also called pneumococcus).

Enrollment: 782 patients

Sex: All

Ages: 50+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Age 50 years and older.
• Presents to a study site with clinically suspected pneumonia.
• Has a radiographic finding that is consistent with pneumonia.
• Able and willing to provide urine.

Exclusion criteria

• Transfer to a study hospital after already being hospitalized for 48 hours or more at any other inpatient facility (such as community hospital).
• Hospital-acquired pneumonia (ie, pneumonia developing 48 hours after hospital admission).
• Previous enrollment in this study within the past 30 days.

Trial design

782 participants in 1 patient group

1

Treatment:

Procedure: Urine sample collection